Orthopaedic News and Research

RSS

Mesoblast moves towards adult stem cell human trials

Exciting Australian adult stem cell company, Mesoblast Limited, today announced that it is set to begin the first human clinical trials using its specialist adult stem cells for orthopaedic and cardiovascular diseases.

30 Mar 2005

Future out-licensing of BioSilicon in tissue engineering and orthopedics

Global nanotechnology company pSivida Limited has announced that it has signed an agreement with US based PureTech Development LLC to investigate and evaluate out-licensing opportunities for BioSilicon with an emphasis on tissue engineering, wound management and orthopedics.

28 Feb 2005

New technologies may offer new treatment options for some patients with degenerative back problems

New technologies may offer new treatment options for some patients with degenerative back problems, according to research presented at the 72nd Annual Meeting of the American Academy of Orthopaedic Surgeons. These latest innovations in spinal surgery could provide promise for hundreds of thousands of U.S. patients who undergo spinal surgery each year.

27 Feb 2005

Surgical treatment of hip or knee arthritis does not reduce obesity

A number of arthritis sufferers attribute their weight gain to inactivity due to a painful hip or knee. These patients may be disheartened when their post-operative weight either remains the same or increases.

27 Feb 2005

Cigarette smokers have an increased risk of experiencing rotator cuff tears

Cigarette smokers have an increased risk of experiencing rotator cuff tears in their shoulders than their tobacco-free counterparts, according to study results presented today at the 72nd Annual Meeting of the American Academy of Orthopaedic Surgeons.

27 Feb 2005

Why women are more susceptible to anterior cruciate ligament (ACL) injuries

New research presented today at the 72nd Annual Meeting of the American Academy of Orthopaedic Surgeons includes important findings on the causes of anterior cruciate ligament (ACL) injuries in female athletes, such as posture and body movement. These findings may be key in the effort to find ways to prevent these types of injuries.

27 Feb 2005

Ankle sprains may predispose a patient to osteoarthritis

Ankle sprains may predispose a patient to osteoarthritis according to a study presented at the American Orthopaedic Foot and Ankle Society’s Annual Winter Meeting in Washington, DC.

27 Feb 2005

New imaging technology may serve as objective outcome measures for orthopedic conditions

New imaging technologies are enabling doctors to not only diagnose a variety of orthopaedic and musculoskeletal conditions with more accuracy, but also to determine with unprecedented precision whether clinical recovery from bone, joint or tendon damage is actually complete and not simply a "placebo effect."

27 Feb 2005

First implant of cryopreserved osteoarticular allograft

CryoLife, a biomaterials and biosurgical device company, announced today that a patient received the first Cryopreserved osteoarticular (OA) allograft transplant for resurfacing articular cartilage in the knee.

23 Feb 2005

Medical House signs 10 year license and supply agreement with BioPartners GmbH

The Medical House, orthopaedic devices and drug delivery company and BioPartners GmbH the global biopharmaceuticals company are pleased to announce a 10 year agreement for license and supply of The Medical House's GH1 reusable, spring-powered, needle-free delivery system for the delivery of BioPartners’ human growth hormone product, Valtropin.

22 Feb 2005

Secreted signaling protein called Wnt10b secret to new drugs for preventing or treating osteoporosis

Leaping tall buildings in a single bound may be out of the question, but the genetically engineered "supermice" in Ormond MacDougald's laboratory at the University of Michigan Medical School are definitely stronger than average.

22 Feb 2005

Mesoblast signs adult stem cells agreement

Australia’s adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.

14 Feb 2005

Zimmer to distribute innovative antibiotic bone cement

Zimmer Holdings announced today it has acquired United States distribution rights for the Palacos line of bone cement products manufactured by Heraeus Kulzer of Germany, a world leader in the development and production of orthopaedic bone cement products and other health care technologies.

3 Feb 2005

Strategic analysis of the European tissue sealants market

Although the USD 90 million European tissue sealants market is in the growth phase, the rate of growth is projected to be gradual due to sluggish technological advancements, the slow pace of collecting clinical evidence and unclear product demarcations. Moreover, while around 35 per cent of all internal surgical procedures offer the potential for sealants' use, their deployment has been limited to only a few procedures.

19 Jan 2005

40-year tale of investigation and innovation into the challenge of hip implant failure

A remarkable story of how a new disease was inadvertently caused by successful medical treatment, ultimately understood, and eventually defeated by scientific innovation is being told a major player in the process.

22 Dec 2004

Removing patient name boards from hospital wards may risk the safe delivery of care to patients

Removing patient name boards from hospital wards because they do not comply with the Data Protection Act 1998 may risk the safe delivery of care to patients, argue researchers in this week's Christmas issue of the BMJ.

20 Dec 2004

PCT waste fears as patients shun new treatment centre

Patients prefer to wait nine months for orthopaedic operations rather than be treated within ten weeks by a new independent treatment centre, a referral centre has found.

13 Dec 2004

Oral contraception can prevent knee injuries as well as unwanted pregnancies

In 1960 the first oral contraception, Enovid-10, was launched in the US market, known as the “pill”. Women were finally enthused about a form of contraception marketed as “safe and effective” and readily used the pill. Within two years oral contraception was used by over 1.2 million women and the numbers continued to rise.

16 Nov 2004

Ultrasound offers new diagnosis for whiplash injury

Lengthy waits for personal injury compensation after car crashes could be a thing of the past, thanks to research being carried out at The University of Nottingham.

6 Oct 2004

Mechanical loading through exercise builds bone strength

Mechanical loading through exercise builds bone strength and this effect is most pronounced during skeletal growth and development, according to Charles H. Turner, professor in the Department of Orthopaedic Surgery and director of orthopaedic research at the Indiana University School of Medicine, Indianapolis.

5 Oct 2004